Apple Inc.
AAPL
$175.49
-3.58 (2.00%)
Principales évolutions du marché à surveiller au cours de la semaine à venir

Publié par MEXEM EUROPE

April 15, 2025
(GMT+2)
Alors que le paysage de l'économie mondiale continue d'évoluer, il est plus important que jamais de comprendre les dernières mises à jour financières. Naviguer dans le monde complexe de la finance peut être accablant, mais se tenir au courant des mouvements significatifs du marché peut permettre aux investisseurs et aux entreprises de prendre des décisions éclairées. Dans l'article qui suit, nous nous penchons sur les cinq tendances et événements financiers les plus importants susceptibles de façonner les marchés au cours de la semaine à venir. Qu'il s'agisse des performances boursières ou des mouvements des dirigeants, nous vous avons fourni les informations essentielles que vous devez connaître.

Goldman Sachs  {{ m-tag option="price" ticker="GS" currency="USD" }}

Overview:

Goldman Sachs, one of the most influential players in the global investment banking and financial services arena, is poised to release its Q1 2025 earnings report on Monday, April 14, before the market opens. The firm has been a bellwether for economic sentiment and capital markets health, making its performance and outlook critical for both institutional and retail investors. Known for its experience in trading, investment management, and advisory services, Goldman Sachs has maintained resilience in a challenging macroeconomic environment shaped by elevated interest rates and geopolitical volatility. Its stock has shown strength heading into the earnings release, with a 2% gain in premarket trading, reflecting optimism among investors about a strong performance.

Financial Analysis:

The consensus among analysts is that Goldman will report earnings per share (EPS) of $12.71, representing a 9.76% increase year-over-year. Revenue from the firm’s trading segment is expected to be a key contributor, especially as recent market volatility has driven elevated activity in both equity and fixed-income markets. Goldman’s diversified business model has enabled it to capitalize on shifting macroeconomic dynamics, with its asset management and consumer banking units also playing a more strategic role in recent quarters. The bank's capital markets operations have benefited from a partial revival in IPO activity and M&A deals, although the pace remains slower than pre-pandemic levels. Additionally, its recent focus on technology-driven trading platforms has enhanced efficiency and profitability in its core operations.

Recent Developments:

Recent news coverage highlights how investment banks, especially those with strong trading arms like Goldman Sachs, may perform well as market uncertainty fuels client activity. The firm’s strategic initiatives in private credit, infrastructure investing, and wealth management are seen as key drivers of potential future revenue growth. Goldman also remains active in sustainability finance and continues expanding its presence in high-growth international markets. With earnings expected to reflect gains in core business segments and possibly updated guidance for 2025, this week’s report will offer important cues on how financial institutions are positioning themselves for a shifting interest rate environment. For investors, Goldman Sachs is not just a financial giant, it’s a real-time barometer of risk appetite and global capital flow.

Johnson & Johnson  {{ m-tag option="price" ticker="JNJ" currency="GBP" }}

Vue d'ensemble :

Johnson & Johnson, a globally diversified healthcare conglomerate, is scheduled to release its Q1 2025 earnings report on Tuesday, April 15, before the U.S. market opens. Known for its robust portfolio spanning pharmaceuticals, medical devices, and consumer health products, J&J is considered a defensive anchor in volatile markets. The company’s long-standing reputation for stability, innovation, and dividend reliability has kept it in favor among long-term investors, even amid mixed short-term sentiment. This week’s earnings release will provide investors with a deeper understanding of how J&J is navigating current headwinds including regulatory scrutiny, tariff adjustments, and competitive dynamics in the drug pipeline. Its recent restructuring and strategic focus following the Kenvue consumer spinoff have further sharpened investor interest.


Financial Analysis:

Accornding to some expect Analysts EPS of $2.59, a slight decline from $2.71 in the same quarter last year, on projected revenues of $21.6 billion, up slightly from the prior year’s $21.4 billion. The pharmaceutical division continues to be a core revenue driver, buoyed by growth in oncology and immunology therapeutics. Newly launched drugs and a robust late-stage pipeline are expected to offset slowing sales from aging blockbuster medications. Meanwhile, the MedTech segment is projected to post modest growth, supported by normalized elective procedure volumes and innovations in minimally invasive surgical tools. However, margin pressure due to inflationary costs and supply chain complexities may weigh on overall earnings quality. On the consumer health front, the Kenvue separation continues to streamline operations and focus capital allocation toward higher-growth verticals.


Recent Developments:

Recent reports from market analysts point to cautious optimism around J&J’s earnings. The company’s acquisition strategy has drawn attention, particularly moves to bolster its pharmaceutical R&D footprint. In addition, management’s commentary on navigating tariff exemptions for key medical components may shed light on future cost efficiencies. The company has also reaffirmed its commitment to shareholder returns with a consistent dividend policy and strong balance sheet management. Given its combination of innovation, operational scale, and cash flow strength, Johnson & Johnson remains a good healthcare pick for investors seeking long-term exposure to the sector with reduced volatility. This week’s results will serve as a key health check for the pharmaceutical industry’s outlook in 2025.

Netflix {{ m-tag option="price" ticker="NFLX" currency="USD" }}

Vue d'ensemble :

‍‍

Netflix, the global leader in subscription-based streaming services, is set to announce its Q1 2025 earnings after the market closes on Thursday, April 17. As one of the most closely watched names in technology and entertainment, Netflix’s performance not only influences investor sentiment within the streaming sector but also serves as a broader indicator of global consumer engagement trends. With its ever-evolving content strategy, geographic expansion, and innovations in advertising and monetization, the company has entered 2025 with a refined focus on profitability and cash flow. This quarter marks a significant milestone as Netflix stops reporting subscriber numbers, shifting investor attention more toward revenue growth and operating margins as the key ways to measure performance.


Financial Analysis:

Analysts forecast Q1 2025 revenue of $10.5 billion, a 12% year-over-year increase, with net income projected at $2.48 billion. The shift to an advertising-supported tier and a widespread crackdown on password sharing have contributed to higher average revenue per user (ARPU) and increased monetization across geographies. The decision to discontinue subscriber count reporting reflects Netflix's confidence in its long-term value drivers, focusing instead on growing engagement and margins. While this change raised some eyebrows initially, major firms like JPMorgan have maintained bullish ratings—JPMorgan recently reaffirmed an “Overweight” rating with a price target of $1,025, citing durable growth and strong international performance. Furthermore, rising production efficiencies and content localization strategies are supporting the company’s improved profitability.


Recent Developments:

Netflix’s upcoming results will also shed light on its evolving competitive posture. With rivals like Disney+, Amazon Prime Video, and Apple TV+ intensifying their own content and pricing strategies, Netflix has responded by diversifying its revenue model and doubling down on regional content creation. In particular, strong engagement in Asia and Latin America has helped offset maturing growth in North America. Analysts will closely watch management’s commentary on content spending, ad revenue performance, and potential pricing adjustments. As the streaming industry matures, Netflix’s ability to lead on innovation while maintaining fiscal discipline will be critical. This earnings release is a litmus test not only for Netflix’s strategy but also for the future of the broader digital entertainment ecosystem.

United Airlines {{ m-tag option="price" ticker="UAL" currency="USD" }}

Vue d'ensemble :

United Airlines, one of the largest U.S. carriers by fleet size and passenger volume, will report its Q1 2025 earnings after the market closes on Tuesday, April 15, followed by an earnings call on Wednesday, April 16. As a major player in both domestic and international air travel, United’s financial performance offers valuable insights into consumer behavior, business travel recovery, and global mobility trends. The airline enters the earnings week on a strong operational footing, having reported record profits in 2024. With expanding international routes, upgraded fleet investments, and solid demand across all travel segments, United is widely seen as a key beneficiary of the ongoing global travel resurgence.

Financial Analysis:

The company previously reported $4.2 billion in full-year pre-tax earnings for 2024, with an adjusted pre-tax margin of 8.0%, indicating strong financial recovery. Analysts expect continued growth momentum in Q1 2025, supported by robust passenger volumes and improved yield management. United’s focus on high-margin transatlantic and Asia-Pacific routes, combined with dynamic pricing strategies, has helped the airline maintain a competitive edge. While fuel prices and labor costs continue to pose headwinds, the airline's ability to manage costs through operational efficiencies and route optimization has bolstered investor confidence. In addition, strong forward bookings and business travel demand are expected to contribute to positive revenue per available seat mile (RASM) trends this quarter.

Recent Developments:

United has been proactive in expanding its fleet and updating its infrastructure to support long-term growth. The airline recently finalized orders for next-generation Boeing and Airbus aircraft, aimed at improving fuel efficiency and reducing its carbon footprint. Management has also emphasized digital innovation, including enhanced booking tools and streamlined loyalty offerings, to capture more wallet share from frequent travelers. Importantly, the company’s commentary during its earnings call will likely include updates on strategic partnerships, pilot recruitment, and expected capacity growth for peak summer travel.

ASML Holding  {{ m-tag option="price" ticker="ASML" currency="USD" }}

Vue d'ensemble :

ASML Holding, the Dutch-based semiconductor equipment powerhouse, is scheduled to report its Q1 2025 earnings on Wednesday, April 16. As the world’s sole manufacturer of extreme ultraviolet (EUV) lithography machines—critical tools used in producing the most advanced semiconductors—ASML plays a pivotal role in enabling next-generation chip manufacturing. Its clients include tech titans like TSMC, Samsung, and Intel, which rely on ASML’s technology to fabricate cutting-edge processors that power everything from AI data centers to consumer electronics. The company’s dominant position in this niche yet essential market makes its earnings and forward guidance influential across the entire semiconductor supply chain.

Financial Analysis:

Analysts project ASML to deliver Q1 2025 earnings per share (EPS) of $6.12, on revenue of $7.90 billion, reflecting a substantial 45.4% year-over-year increase. This performance is underpinned by sustained demand for EUV and DUV (deep ultraviolet) systems, particularly as AI workloads and advanced logic chips drive increased capital expenditures from foundries. According to estimates compiled by Reuters, total revenue is expected to climb to €7.691 billion (about $8.3 billion), up from €5.29 billion a year ago. The company's order backlog remains robust, with EUV system sales making up a growing portion of its revenue mix. While the macro environment remains volatile due to trade policies and geopolitical friction, ASML's technology leadership continues to act as a buffer, giving it pricing power and long-term visibility.

Recent Developments:

The upcoming earnings call will be closely scrutinized for commentary on export restrictions to China, which remain a regulatory overhang. However, ASML has previously downplayed short-term risks, citing diversified geographic demand and strong replacement cycles across mature and leading-edge nodes. Management’s outlook on capacity expansion and production timelines for the upcoming high-NA EUV systems will also be a focal point, especially given rising demand from AI and HPC (high-performance computing) customers. The firm’s ongoing investments in R&D and supplier base optimization further reinforce its position as a key enabler of Moore’s Law. For investors, ASML’s report this week will offer crucial signals on capital investment trends across the tech landscape and the structural drivers behind the global semiconductor boom.

Conclusion

As earnings season accelerates, the coming week offers a concentrated dose of insight into the health and trajectory of several major sectors. Reports from Goldman Sachs and United Airlines will reveal how financial institutions and travel operators are navigating macroeconomic fluctuations, consumer confidence, and cost dynamics. Meanwhile, Johnson & Johnson and ASML are poised to offer important updates from the healthcare and semiconductor industries—two areas heavily influenced by innovation, regulation, and global supply chain shifts. Netflix, straddling technology and media, represents a bellwether for consumer engagement and monetization strategy in the maturing streaming landscape.

Investors should pay close attention to forward guidance, margin trends, and strategic commentary across these companies. The breadth of sectors represented—finance, healthcare, tech, AI, entertainment, and air transportation—will provide valuable signals for broader market sentiment and help inform allocation decisions for the next quarter.



Les informations contenues dans le site mexem.com sont données à titre d'information générale uniquement. Elles ne doivent pas être considérées comme des conseils en matière d'investissement. Investir dans des actions comporte des risques. Les performances passées d'une action ne sont pas un indicateur fiable de ses performances futures. Consultez toujours un conseiller financier ou des sources fiables avant de prendre toute décision d'investissement.

QUE LIRE ENSUITE ?

Prêt à commencer ?

Commencez à trader avec une offre complète, allant d'une plateforme à la pointe de la technologie à des outils gratuits et des frais de transaction avantageux.